Sign inGet started

Cavan John T

Insider CIK 1503738 · CTRV Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
HEPA Hepion Pharmaceuticals, In A Award deriv2021-05-182021-05-201,200,000— $01,581,060SEC↗
HEPA Hepion Pharmaceuticals, In P Buy2021-02-182021-02-1810,000$2.00 $20.0K14,800SEC↗
HEPA Hepion Pharmaceuticals, In P Buy2020-11-252020-11-304,500$1.62 $7.3K4,800SEC↗
HEPA Hepion Pharmaceuticals, In A Award deriv2020-08-192020-08-21160,000— $0381,060SEC↗
HEPA Hepion Pharmaceuticals, In A Award deriv2020-04-032020-04-07215,000— $0221,059SEC↗
HEPA Hepion Pharmaceuticals, In A Award deriv2019-07-242019-07-255,820— $06,059SEC↗
CTRV ContraVir Pharmaceuticals, P Buy deriv2018-07-032018-07-0315$1000.00 $15.0K15SEC↗
CTRV ContraVir Pharmaceuticals, P Buy deriv2018-07-032018-07-038,625$1000.00 $8.63M8,625SEC↗
CTRV ContraVir Pharmaceuticals, A Award2018-01-032018-01-05101,221— $0167,947SEC↗
CTRV ContraVir Pharmaceuticals, A Award deriv2017-07-202017-07-2115,000— $0133,688SEC↗
CTRV ContraVir Pharmaceuticals, A Award2017-07-062017-07-0746,726— $066,726SEC↗
CTRV ContraVir Pharmaceuticals, P Buy2017-06-202017-06-2220,000$0.65 $13.0K20,000SEC↗
CTRV ContraVir Pharmaceuticals, A Award deriv2016-08-262016-08-2918,688— $0118,688SEC↗